MedTrace Logo

OST and MORES in Male Osteoporosis

NCT07518212 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 140

Last updated 2026-04-08

No results posted yet for this study

Summary

The aim of this study is to compare the Male Osteoporosis Risk Score and the Osteoporosis Self-Assessment Tool with the gold standard DEXA in determining the risk of osteoporosis in the lumbar and femoral regions in male individuals in the Turkish population, and to investigate their sensitivity and specificity in the first stage of screening for the detection of male osteoporosis.

Conditions

  • Male Osteoporosis

Sponsors & Collaborators

  • Kayseri City Hospital

    lead OTHER_GOV

Principal Investigators

  • Fatma Gül Ülkü Demir, MD · Kayseri City Hospital

Eligibility

Min Age
50 Years
Max Age
75 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-02-04
Primary Completion
2026-07-01
Completion
2026-09-15

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07518212 on ClinicalTrials.gov